Inmune Bio, Inc. (INMB)

Typically moves ±5.59% on earnings

EARNINGS ANALYTICS

event_upcoming Next Earnings: 2026-08-04 HIGH CONFIDENCE

Since May 06, 2021, Inmune Bio, Inc. (INMB) has reported earnings 18 times. On average the shares move ±5.59% post-earnings, with a positive reaction 61.1% of the time. Its largest post-earnings gain was +8.54% (Aug 08, 2023) and its largest decline was -19.06% (Nov 04, 2021). The next earnings report is predicted for 2026-08-04 (high confidence).

Earnings reactions

How INMB moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

Avg Abs. Movement

±5.59%

Positive %

61.1%

Negative %

38.9%

Historical Earnings Statistics

Date	Timing	Earnings move	SEC Filing
Oct 30, 2025	☽ POST	+5.78%	open_in_new
Aug 07, 2025	☽ POST	-8.24%	open_in_new
May 08, 2025	☽ POST	-1.69%	open_in_new
Mar 27, 2025	☽ POST	+1.48%	open_in_new
Nov 01, 2024	☽ POST	+3.48%	open_in_new
Aug 02, 2024	☽ POST	-6.49%	open_in_new
May 13, 2024	☽ POST	+5.75%	open_in_new
Nov 01, 2023	☽ POST	-3.82%	open_in_new
Aug 08, 2023	☽ POST	+8.54%	open_in_new
May 04, 2023	☽ POST	+6.61%	open_in_new
Mar 03, 2023	☽ POST	-4.11%	open_in_new
Nov 02, 2022	☽ POST	+4.85%	open_in_new
Aug 04, 2022	☽ POST	+0.78%	open_in_new
May 06, 2022	☀ PRE	+3.87%	open_in_new
Mar 04, 2022	☽ POST	-7.96%	open_in_new
Nov 04, 2021	☽ POST	-19.06%	open_in_new
Aug 05, 2021	☽ POST	+5.89%	open_in_new
May 06, 2021	☽ POST	+2.2%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±5.59%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Mar 31, 2026 · SEC 13-F

View all 13 →

Funds holding

$2601645

Total value held

Buying

7 added · 6 reduced

Blackrock, Inc.

$1349347 -1.48%

State Street Corp

$328693 -16.24%

Goldman Sachs Group Inc

$261692 +310.05%

Raymond James Financial Inc

$229667 -3.53%

Northern Trust Corp

$208174 +4.88%

SEC Filing Types

Recent SEC Filings

10 most recent

Form	Date Filed	View on EDGAR
4	20260707	open_in_new SEC.gov
4	20260707	open_in_new SEC.gov
4	20260707	open_in_new SEC.gov
8-K	20260701	open_in_new SEC.gov
8-K	20260623	open_in_new SEC.gov
8-K	20260617	open_in_new SEC.gov
8-K	20260602	open_in_new SEC.gov
8-K	20260514	open_in_new SEC.gov
10-Q	20260507	open_in_new SEC.gov
8-K	20260505	open_in_new SEC.gov

Frequently asked about INMB earnings

When does Inmune Bio, Inc. report earnings next? expand_more

Inmune Bio, Inc. (INMB)'s next earnings date is predicted (high confidence) for 2026-08-04. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does INMB stock move after earnings? expand_more

Over 18 reports, INMB has moved an average of ±5.59% the session after earnings, closing higher 61.1% of the time.

What was INMB's biggest post-earnings move? expand_more

INMB's largest post-earnings gain on record was +8.54% on Aug 08, 2023, and its largest decline was -19.06% on Nov 04, 2021.

Where can I find Inmune Bio, Inc.'s SEC filings? expand_more

All of Inmune Bio, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.